Interestingly, the use of anti-Gr1 antibody also induces an increase of CD8+ and CD4+ T cells within the tumor, suggesting that VEGF-A reduces the infiltration of cytotoxic T lymphocyte through MDSC [43]. Here, VEGFA is linked to neoplasm.